JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120159

(R)-CPP, NMDA antagonist

Be the first to review this product! Submit a review

|

(25 Publications)

MW 252.2 Da. Highly potent, competitive NMDA antagonist; more active enantiomer of (RS)-CPP (ab120160). (Ki values are 0.04, 0.3, 0.6 and 2.0 μM at NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D, respectively).
2 Images
Functional Studies - (R)-CPP, NMDA antagonist (AB120159)
  • FuncS

PubMed

Functional Studies - (R)-CPP, NMDA antagonist (AB120159)

Transporter blockade does not reveal an ambient glutamate concentration gradient between extracellular compartments.

A. Average Ca2+ increase in a spine during a 40 ms voltage step, with iontophoresis of L-aspartate (black), without iontophoresis (red), a second L-aspartate application (gray), L-aspartate in the presence of 100 μM TBOA (blue), and TBOA alone (green).

B. Comparison of spine Ca2+ transients in each condition, normalized to the first response to L-aspartate iontophoresis (n = 5). Error bars indicate SEM. Significance determined by Friedman ANOVA with Conover posthoc test : *p<0.05; **p<0.01; ***p<0.001.

If the extrasynaptic glutamate concentration is higher than that in the cleft because transporters prevent diffusion of glutamate into the synapse, blocking transporters should result in a large Ca2+ increase in the spine as extrasynaptic glutamate rushes into the cleft and activates synaptic NMDARs. Spines exhibited a Ca2+ increase during a 40 ms depolarization with iontophoresis of the glutamate transporter substrate and NMDAR agonist, L-aspartate (A; black and gray traces), confirming the presence of NMDARs. However, TBOA (100 μM) did not increase the Ca2+ transient in the same spines during the 40 ms depolarization when compared to the control voltage step without L-aspartate iontophoresis (See image compare green and red traces; 20.6±13.62%; p>0.5; n = 5;). TBOA was effective in blocking transporters, however, as the NMDAR-mediated Ca2+ signal evoked by iontophoresis of L-aspartate was increased in the presence of TBOA (See image). This result indicates that glutamate transporters do not normally generate a concentration gradient of ambient glutamate between extrasynaptic and synaptic extracellular compartments.

Herman et al PLoS One. 2011;6(11):e26501. doi: 10.1371/journal.pone.0026501. Epub 2011 Nov 1. Fig 3. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Chemical Structure - (R)-CPP, NMDA antagonist (AB120159)
  • Chemical Structure

Lab

Chemical Structure - (R)-CPP, NMDA antagonist (AB120159)

2D chemical structure image of ab120159, (R)-CPP, NMDA antagonist

Key facts

CAS number

126453-07-4

Form

Solid

form

Molecular weight

252.2 Da

Molecular formula

C<sub>8</sub>H<sub>1</sub><sub>7</sub>N<sub>2</sub>O<sub>5</sub>P

PubChem

6603754

Nature

Synthetic

Biochemical name

(R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid

Biological description

Highly potent, competitive NMDA antagonist; more active enantiomer of (RS)-CPP (ab120160). (Ki values are 0.04, 0.3, 0.6 and 2.0 μM at NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D, respectively).

Canonical smiles

C1CN(CC(N1)C(=O)O)CCCP(=O)(O)O

Isomeric smiles

C1CN(C[C@@H](N1)C(=O)O)CCCP(=O)(O)O

InChi

InChI=1S/C8H17N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h7,9H,1-6H2,(H,11,12)(H2,13,14,15)/t7-/m1/s1

InChiKey

CUVGUPIVTLGRGI-SSDOTTSWSA-N

IUPAC Name

(2R)-4-(3-phosphonopropyl)piperazine-2-carboxylic acid

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The N-Methyl-D-Aspartate Receptor (NMDAR) subunits such as NMDAR2A NMDAR2B GluN2C NMDAR1 GluN2D NR3A and NR3B are key components of glutamate receptors also including the AMPA subtype Glutamate Receptor 1. These receptors are ionotropic and mediate synaptic transmission in the central nervous system. They are expressed in the brain particularly in regions such as the hippocampus and cortex. NMDAR1 also known as GluN1 serves as an obligatory subunit required for functional receptor assembly. The mass of NMDAR subunits varies; for example the GluN1 subunit has an approximate mass of 120 kDa.
Biological function summary

These glutamate receptor subunits forming part of NMDAR and AMPA receptor complexes modulate synaptic plasticity which underlies learning and memory. NMDARs are tetrameric complexes composed mostly of two GluN1 subunits combined with two region-specific GluN2 (A-D) or GluN3 (A B) subunits creating diversity in function and pharmacological characteristics. The AMPA receptor primarily built of GluA1 through GluA4 subunits contributes to fast excitatory neurotransmission. Together these receptors regulate calcium ion flow into neurons impacting cellular events essential for neural communication and adaptation.

Pathways

NMDARs and AMPA receptors integrate into key neural and signaling pathways such as the long-term potentiation pathway which is essential for memory formation. NMDAR activation allows calcium influx necessary for initiating intracellular signaling cascades. The interactions with proteins like CaMKII and synaptic scaffolds like PSD-95 illustrate the role of these receptors in synaptic and protein signaling networks that adjust synaptic strength.

NMDAR and AMPA receptors have massive implications in neurodegenerative diseases like Alzheimer's and neuropsychiatric disorders such as schizophrenia. Dysregulation in NMDAR function possibly through inadequate blockade by antagonists like D-AP5 or D-APV links to excitotoxicity a condition contributing to neuronal death as seen in Alzheimer's. In schizophrenia altered NMDAR signaling is connected to cognitive dysfunction and both NMDAR and AMPA may serve as therapeutic targets.

Product protocols

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

eLife 13: PubMed40013677

2025

Characterization of direct Purkinje cell outputs to the brainstem.

Applications

Unspecified application

Species

Unspecified reactive species

Christopher H Chen,Zhiyi Yao,Shuting Wu,Wade G Regehr

eLife 13: PubMed39819796

2025

Realistic mossy fiber input patterns to unipolar brush cells evoke a continuum of temporal responses comprised of components mediated by different glutamate receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Vincent Huson,Wade G Regehr

STAR protocols 5:103255 PubMed39146190

2024

Protocol for electrophysiological measurements of circadian changes in excitability in dentate granule cells from adult mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jose Carlos Gonzalez,Haeun Lee,Linda Overstreet-Wadiche

Cell reports 42:112039 PubMed36749664

2023

Circadian regulation of dentate gyrus excitability mediated by G-protein signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Jose Carlos Gonzalez,Haeun Lee,Angela M Vincent,Angela L Hill,Lacy K Goode,Gwendalyn D King,Karen L Gamble,Jacques I Wadiche,Linda Overstreet-Wadiche

Cell reports 39:110795 PubMed35545050

2022

Serotonin receptors contribute to dopamine depression of lateral inhibition in the nucleus accumbens.

Applications

Unspecified application

Species

Unspecified reactive species

Dennis A Burke,Veronica A Alvarez

eLife 10: PubMed34369877

2021

Purkinje cell outputs selectively inhibit a subset of unipolar brush cells in the input layer of the cerebellar cortex.

Applications

Unspecified application

Species

Unspecified reactive species

Chong Guo,Stephanie Rudolph,Morgan E Neuwirth,Wade G Regehr

eLife 10: PubMed33616036

2021

Incomplete removal of extracellular glutamate controls synaptic transmission and integration at a cerebellar synapse.

Applications

Unspecified application

Species

Unspecified reactive species

Timothy S Balmer,Carolina Borges-Merjane,Laurence O Trussell

The Journal of neuroscience : the official journal of the Society for Neuroscience 41:594-612 PubMed33303678

2020

Purinergic Signaling Controls Spontaneous Activity in the Auditory System throughout Early Development.

Applications

Unspecified application

Species

Unspecified reactive species

Travis A Babola,Sally Li,Zhirong Wang,Calvin J Kersbergen,Ana Belén Elgoyhen,Thomas M Coate,Dwight E Bergles

eLife 9: PubMed33259288

2020

Cerebellar and vestibular nuclear synapses in the inferior olive have distinct release kinetics and neurotransmitters.

Applications

Unspecified application

Species

Unspecified reactive species

Josef Turecek,Wade G Regehr

Cell reports 33:108338 PubMed33147470

2020

Cerebellum-Specific Deletion of the GABA Receptor δ Subunit Leads to Sex-Specific Disruption of Behavior.

Applications

Unspecified application

Species

Unspecified reactive species

Stephanie Rudolph,Chong Guo,Stan L Pashkovski,Tomas Osorno,Winthrop F Gillis,Jeremy M Krauss,Hajnalka Nyitrai,Isabella Flaquer,Mahmoud El-Rifai,Sandeep Robert Datta,Wade G Regehr
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com